The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
